<--- Back to Details
First PageDocument Content
Asthma / Immunology / Peak expiratory flow / Allergy / Omalizumab / International Study of Asthma and Allergies in Childhood / Pathophysiology of asthma / Medicine / Pulmonology / Respiratory therapy
Date: 2008-06-05 16:28:06
Asthma
Immunology
Peak expiratory flow
Allergy
Omalizumab
International Study of Asthma and Allergies in Childhood
Pathophysiology of asthma
Medicine
Pulmonology
Respiratory therapy

Doctor explaining to child

Add to Reading List

Source URL: health.utah.gov

Download Document from Source Website

File Size: 1,37 MB

Share Document on Facebook

Similar Documents

Medicine / Immunology / Immune system / Clinical medicine / Omalizumab / Immunoglobulin E / Allergen / Plasmacytoid dendritic cell / Allergy / Immunogen / TLR9 / Dendritic cell

Curing Allergic Diseases S-TARget therapeutics GmbH Mooslackengasse 17, 1190 Vienna, Austria. Phone:+, +, +Confidential

DocID: 1rgTJ - View Document

Medicine / Immunology / Clinical medicine / Immune system / Allergology / Glycoproteins / Monoclonal antibodies / Omalizumab / Immunoglobulin E / Asthma / Allergic conjunctivitis / Allergen

Validation of Peptide Immunotherapy as a New Approach in the Treatment of Allergic Rhinoconjunctivitis: The Clinical Benefits of Treatment with Amb a 1 Derived T cell Epitopes

DocID: 1qs00 - View Document

Health / Health economics / Healthcare quality / Personal life / Quality-adjusted life year / Omalizumab / Quality of life / National Institute for Health and Care Excellence / ICD-10 / Life expectancy

Microsoft Word - VBP WSB implementation part 2 (December 12)

DocID: 1qi5u - View Document

Immune system / Blood tests / Monoclonal antibodies / Phadia / Glycoproteins / RTT / Omalizumab / Immunoglobulin E / Allergy

Milenia QuickLine Total IgE Beta side-Evaluation Milenia QuickLine Total IgE (MQTE) and Milenia POCScan (MSCAN) reader:

DocID: 1plJT - View Document

Medicine / Clinical medicine / Health care / Asthma / Immune system / Immunology / Allergology / Respiratory therapy / Allergy / Allergen / Epidemiology of asthma / Omalizumab

NATIONAL ACADEMY ON AN AGING SOCIETY The number of children with asthma has risen about 75 percent sinceIn 1996,

DocID: 1ljn3 - View Document